Risk of hypertension in cancer patients treated with abiraterone: a meta-analysis

Abstract Background Hypertension is one of the major side effects associated with abiraterone in the treatment of advanced prostate cancer. The specific contribution of abiraterone to hypertension has not been defined. We performed a systematic review and meta-analysis of randomized clinical trials...

Full description

Bibliographic Details
Main Authors: Xiaolei Zhu, Shenhong Wu
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Clinical Hypertension
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40885-019-0116-x